Palmitoylrhizoxin — CAS 1035240-98-1

Palmitoylrhizoxin is a palmitoylated derivative of rhizoxin, a macrolide compound originally isolated from the plant pathogenic fungus Rhizopus microsporus. It exhibits potent antimitotic activity by binding to tubulin and inhibiting microtubule polymerization. Mediocon Inc manufactures this speciality API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Research and development in antifungal therapy
• Investigational antimitotic agent in oncology research
• Study of tubulin-binding mechanisms
• Potential lead compound for anticancer drug development

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support